General Archive
-
News releasesNew £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya
A new £6.2m healthcare project has begun in Kenya to advance elimination of visceral leishmaniasis, a deadly parasitic disease found…
-
News releasesLifeArc supports 8 new fellows through Crick Africa Network (CAN) partnership
The Crick Africa Network (CAN), a partnership between LifeArc, the Francis Crick Institute and 5 African institutions, has now awarded…
-
News releasesLifeArc signs statement calling for the UK to lead the G7 on R&D investment
The Campaign for Science and Engineering (CaSE) has released a joint statement urging all political parties to commit the UK…
-
News releasesLifeArc funds pivotal clinical trial to treat an ultra-rare genetic disease with possible link to leader of the mutiny on the Bounty in 1789
A pivotal clinical trial to look at repurposing the UK-licensed medicine, deferiprone, for patients with neuroferritinopathy, an ultra-rare genetic disease…
-
News releasesReAct Africa and LifeArc announce launch of ASPIRE initiative to combat antimicrobial resistance in Zambia and Kenya
ReAct (Action on Antibiotic Resistance) Africa, in partnership with self-funded medical research organisation and charity LifeArc, is excited to introduce…
-
News releasesLifeArc joins £20m international project to develop novel cancer treatment for children
LifeArc is investing up to £4.9 million to bolster a joint international project to create new cancer therapies specifically for…
-
News releasesLifeArc’s Edinburgh labs featured in STV segment about innovations for people living with bronchiectasis
Recently, our team had the pleasure of hosting STV for an exciting feature at the BioQuarter campus in Edinburgh. Watch…
-
News releasesLifeArc welcomes Labour Life Sciences sector plan
Ahead of an upcoming general election, it is important that all political parties consider how they would support the life…
-
News releasesLifeArc makes multi-million pound investment to support drug discovery in sub-Saharan Africa
LifeArc and the Bill & Melinda Gates Foundation are jointly investing £6 million ($7.2m) in the Grand Challenges African Drug…
-
News releasesLifeArc Ventures: Six new investments, portfolio progress and an expanding investment team
LifeArc Ventures, which is committed to investing in innovative early-stage life science companies, today provides an update on its portfolio.…
-
News releasesTwo influential life science leaders join LifeArc science team
This quarter, we look forward to welcoming 2 new colleagues – Heather McKinnon and Giovanna Lalli – to strategic leadership…
-
News releasesNHS trial uses artificial intelligence to predict severe infections and transform lives of people living with chronic lung conditions
A new NHS trial is using a home monitoring app combined with artificial intelligence (AI) to predict when people living…